| 6611- | Ech, | Proliferative activity of a blend of Echinacea angustifolia and Echinacea purpurea root extracts in human vein epithelial, HeLa, and QBC-939 cell lines, but not in Beas-2b cell lines |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | BEAS-2B | - | in-vitro, | Nor, | HUVECs |
| 6614- | Ech, | Echinacea: a Miracle Herb against Aging and Cancer? Evidence In vivo in Mice |
| - | in-vivo, | Var, | NA |
| 6613- | Ech, | Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system |
| - | Study, | Nor, | NA |
| 6612- | Ech, | Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | Nor, | NA |
| 6603- | Ech, | doxoR, | The effect of Echinacea purpurea on the pharmacokinetics of docetaxel |
| - | Trial, | Var, | NA |
| 6604- | Ech, | Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion |
| - | Human, | Nor, | NA |
| 6605- | Ech, | Bioavailability of Echinacea Constituents: Caco-2 Monolayers and Pharmacokinetics of the Alkylamides and Caffeic Acid Conjugates |
| - | Human, | Nor, | NA |
| 6606- | Ech, | Cic, | Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | Colon, | HCT116 |
| 6607- | Ech, | Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | CRC, | Colo320 |
| 6608- | Ech, | CBC, | The pro-apoptosis effects of Echinacea purpurea and Cannabis sativa extracts in human lung cancer cells through caspase-dependent pathway |
| - | in-vitro, | Lung, | A549 |
| 6609- | Ech, | Cic, | Echinacea purpurea Extract Enhances Natural Killer Cell Activity In Vivo by Upregulating MHC II and Th1-type CD4+ T Cell Responses |
| - | in-vivo, | Nor, | NA |
| 6610- | Ech, | Cic, | A standardized extract of Echinacea purpurea containing higher chicoric acid content enhances immune function in murine macrophages and cyclophosphamide-induced immunosuppression mice |
| - | in-vivo, | Nor, | NA |
| 6634- | Ech, | Echinacea purpurea: Pharmacology, phytochemistry and analysis methods |
| - | Review, | Var, | NA |
| 6621- | Ech, | Cisplatin, | Experimental Evaluation of Protective Activity of Echinacea pallida against Cisplatin Toxicity |
| - | in-vivo, | Nor, | NA |
| 6620- | Ech, | Echinacea purpurea diminishes neovascular reaction induced in mice skin by human cancer cells and stimulates non-specific cellular immunity in humans |
| - | in-vivo, | Var, | NA |
| 6619- | Ech, | Echinacea Reduces Antibiotics by Preventing Respiratory Infections: A Meta-Analysis (ERA-PRIMA) |
| - | Review, | Nor, | NA |
| 6618- | Ech, | Kaempferols from Echinacea purpurea demonstrate anti-cancer potential by targeting anexelekto in breast cancer therapy using chemoinformatics approach |
| - | Analysis, | BC, | NA |
| 6617- | Ech, | Echinacea Angustifolia DC Extract Induces Apoptosis and Cell Cycle Arrest and Synergizes with Paclitaxel in the MDA-MB-231 and MCF-7 Human Breast Cancer Cell Lines |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 |
| 7192- | EGb 761, | Ginkgo biloba extract EGb 761 exerts anti-angiogenic effects via activation of tyrosine phosphatases |
| - | in-vitro, | Nor, | HMEC |
| 7191- | EGb 761, | Pharmacokinetic drug interactions involving Ginkgo biloba |
| - | Review, | AD, | NA |
| 7193- | EGb 761, | 5-FU, | Ginkgo biloba extract 761 enhances 5-fluorouracil chemosensitivity in colorectal cancer cells through regulation of high mobility group-box 3 expression |
| - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | SW-620 |
| 7209- | EGb 761, | Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review |
| - | Review, | AD, | NA |
| 7208- | EGb 761, | EGb 761 reduces Ca2+ influx and apoptosis after pentylenetetrazole treatment in a neuroblastoma cell line |
| - | in-vitro, | Nor, | SH-SY5Y |
| 7203- | EGb 761, | Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials |
| - | Review, | AD, | NA |
| 7202- | EGb 761, | Ginkgo biloba leaf extract EGb 761® for the treatment of various diseases: Overview of systematic reviews |
| - | Review, | AD, | NA |
| 7200- | EGb 761, | PCA, | Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference |
| - | in-vivo, | Nor, | NA |
| 7196- | EGb 761, | Ginkgo biloba extract EGb 761 in patients with dementia and a history of cerebral infarction-meta-analysis of pooled data from randomised clinical trials |
| - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 7194- | EGb 761, | Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells |
| - | in-vitro, | Oral, | NA |
| 7225- | EGb 761, | Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial |
| - | Trial, | AD, | NA |
| 7235- | EGb 761, | Stabilization of Mitochondrial Membrane Potential and Improvement of Neuronal Energy Metabolism by Ginkgo Biloba Extract EGb 761 |
| - | in-vitro, | AD, | NA |
| 7236- | EGb 761, | Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia |
| - | in-vivo, | Stroke, | NA |
| 7232- | EGb 761, | Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial |
| - | Trial, | AD, | NA |
| 7231- | EGb 761, | Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials |
| - | Review, | AD, | NA |
| 7230- | EGb 761, | Ginkgo biloba extract (EGb 761) promotes peripheral nerve regeneration and neovascularization after acellular nerve allografts in a rat model |
| - | in-vivo, | Nor, | NA |
| 7229- | EGb 761, | Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia |
| - | Review, | AD, | NA |
| 7228- | EGb 761, | Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders |
| - | Review, | AD, | NA |
| 7237- | EGb 761, | Ginkgo biloba Extract Mechanism Inhibits Hepatocellular Carcinoma through the Nuclear Factor-κB/p53 Signaling Pathway |
| - | in-vitro, | HCC, | HepG2 |
| 7222- | EGb 761, | Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use |
| - | Review, | AD, | NA |
| 7239- | EGb 761, | Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 7220- | EGb 761, | Ginkgo Biloba Extract Inhibits Metastasis and ERK/Nuclear Factor kappa B (NF-κB) Signaling Pathway in Gastric Cancer |
| - | vitro+vivo, | GC, | SGC-7901 |
| 7219- | EGb 761, | Ginkgo biloba Prevents Oxidative Stress-Induced Apoptosis Blocking p53 Activation in Neuroblastoma Cells |
| - | in-vitro, | Nor, | SK-N-BE |
| 7240- | EGb 761, | EGb 761 protects liver mitochondria against injury induced by in vitro anoxia/reoxygenation |
| - | in-vitro, | Nor, | NA |
| - | Trial, | Nor, | NA |
| 3721- | EGb 761, | Ginkgo biloba Extract in Alzheimer’s Disease: From Action Mechanisms to Medical Practice |
| - | Review, | AD, | NA |
| 3428- | EGCG, | Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex |
| - | Review, | Var, | NA |
| 3217- | EGCG, | Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke |
| - | in-vivo, | Stroke, | NA |
| 3229- | EGCG, | Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells |
| - | in-vitro, | Nor, | HMEC | - | in-vitro, | Nor, | HUVECs |
| 3230- | EGCG, | Green Tea Polyphenol Epigallocatechin 3-Gallate, Contributes to the Degradation of DNMT3A and HDAC3 in HCT 116 Human Colon Cancer Cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HT29 |
| 3228- | EGCG, | Targeting fibrotic signaling pathways by EGCG as a therapeutic strategy for uterine fibroids |
| - | in-vitro, | Nor, | NA |
| 3227- | EGCG, | Epigallocatechin-3-gallate treatment to promote neuroprotection and functional recovery after nervous system injury |
| - | in-vivo, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid